Optometrists in Ozone Park, NY Accepting Medicare

8 Optometrists found. Showing 1 - 8

Joanne Deveau, OD Optometrist Medicare: Not Enrolled in Medicare Practice Location: 10222 Atlantic Ave, Ozone Park, NY 11416 Phone: 718-846-1144

Dr. Asghar G. Dedhar, O.D. Optometrist Medicare: Medicare Enrolled Practice Location: 102-22 Atlantic Avenue, Sap Optical Inc, Ozone Park, NY 11416 Phone: 718-846-1144

Solomon Matatov Optometrist Medicare: Not Enrolled in Medicare Practice Location: 10505 Crossbay Blvd, Ozone Park, NY 11417 Phone: 718-366-8193

Sap Optical Optometrist Medicare: Not Enrolled in Medicare Practice Location: 10222 Atlantic Ave, Ozone Park, NY 11416 Phone: 718-846-1144    Fax: 718-849-1146

Jeannette M Cooper, O.D. Optometrist Medicare: Not Enrolled in Medicare Practice Location: 10222 Atlantic Ave, Ozone Park, NY 11416 Phone: 718-846-1144

Vision World Optometrist Medicare: Not Enrolled in Medicare Practice Location: 91-12a Atlantic Avenue, Ozone Park, NY 11416 Phone: 718-845-3737    Fax: 718-641-8461

Inrava Khasnabish, O.D. Optometrist Medicare: Accepting Medicare Assignments Practice Location: 10222 Atlantic Ave, Ozone Park, NY 11416 Phone: 718-846-1144

Pearle Vision Optometrist Medicare: Medicare Enrolled Practice Location: 10222 Atlantic Ave, Ozone Park, NY 11416 Phone: 718-846-1144    Fax: 347-772-3032

News Archive

Molecule plays essential role in establishing proper neural wiring in the cerebellum

Researchers at Hokkaido University have found that the molecule "L-gutamate/L-aspartate transporter" (GLAST) plays an essential role in establishing and maintaining proper neural wiring of Purkinje cells in the cerebellum.

Sanford-Burnham, Florida Hospital and Moffitt partner to develop PMP Florida

Moffitt Cancer Center, Sanford-Burnham Medical Research Institute and Florida Hospital have announced they will collaborate on the creation of a Personalized Medicine Partnership of Florida (PMP Florida). The partnership will conduct collaborative research to accelerate discovery and develop new treatments in the areas of cancer and metabolic diseases, including obesity, diabetes and cardiovascular disease.

MATH biomarker with HPV status may provide improved outcomes in HNSCC patients

Evaluating next-generation sequencing (NGS) data and associated clinical records of head and neck squamous cell carcinoma (HNSCC) patients from several institutions, made available through The Cancer Genome Atlas (TCGA), showed that combining Mutant-Allele Tumor Heterogeneity (MATH) as a biomarker with the patient's HPV status provides an effective indicator of improved patient outcome, according to research presented today at the 2014 Multidisciplinary Head and Neck Cancer Symposium.

Obese women more likely to have breast cancer at later stage: Study

Obese women are more likely to have breast cancer detected at a later stage and to have lymph node metastases when diagnosed than women who are not obese, according to a study presented this week at the Annual Meeting of the American Society of Breast Surgeons.

FASgen receives $1.4 million SBIR Phase II NIH grant for obesity research

FASgen, Inc. is pleased to announce that it was awarded a new $1.4 million SBIR Phase II NIH grant for continued research for obesity. FASgen has for some time had extensive research into the effects of inhibition of the fatty acid biosynthesis pathway on the regulation of appetite and weight loss.

Read more Medical News

› Verified 5 days ago